(Q52011141)

19 April 2018

title

Biochemical failure as a determinant of distant metastasis and death in prostate cancer treated with radiotherapy. (English)

1 reference

19 April 2018

Adaptive radiation therapy

main subject

0 references

author name string

Alan Pollack

1

1 reference

19 April 2018

Alexandra L Hanlon

2

1 reference

19 April 2018

Benjamin Movsas

3

1 reference

19 April 2018

Gerald E Hanks

4

1 reference

19 April 2018

Robert Uzzo

5

1 reference

19 April 2018

Eric M Horwitz

6

1 reference

19 April 2018

language of work or name

English

0 references

publication date

1 September 2003

1 reference

19 April 2018

International Journal of Radiation Oncology Biology Physics

published in

1 reference

19 April 2018

volume

57

1 reference

19 April 2018

issue

1

1 reference

19 April 2018

page(s)

19-23

1 reference

19 April 2018

The fall and rise of prostate-specific antigen. Kinetics of serum prostate-specific antigen levels after radiation therapy for prostate cancer

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900538-8

7 January 2021

Prostate specific antigen doubling time and disease relapse after radiotherapy for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900538-8

7 January 2021

Kinetics of serum prostate-specific antigen after external beam radiation for clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900538-8

7 January 2021

Natural history of progression after PSA elevation following radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900538-8

7 January 2021

The correlation between the ASTRO Consensus Panel definition of biochemical failure and clinical outcome for patients with prostate cancer treated with external beam irradiation. American Society of Therapeutic Radiology and Oncology

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900538-8

7 January 2021

Overall survival after prostate-specific-antigen-detected recurrence following conformal radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900538-8

7 January 2021

Impact of biochemical failure on overall survival after radiation therapy for localized prostate cancer in the PSA era.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900538-8

7 January 2021

In regard to Kupelian et al.: impact of biochemical failure on overall survival after radiation therapy for localized prostate cancer in the PSA era. IJROBP 2002;52:704-711

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900538-8

7 January 2021

Influence of prostate-specific antigen testing on the spectrum of patients with prostate cancer undergoing radical prostatectomy at a large referral practice

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900538-8

7 January 2021

Cancer surveillance series: interpreting trends in prostate cancer--part I: Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900538-8

7 January 2021

Declining rates of extracapsular extension after radical prostatectomy: evidence for continued stage migration

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900538-8

7 January 2021

Evolution of the presentation and pathologic and biochemical outcomes after radical prostatectomy for patients with clinically localized prostate cancer diagnosed during the PSA era

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900538-8

7 January 2021

Fifteen-year minimum follow-up of a prostate brachytherapy series: comparing the past with the present

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900538-8

7 January 2021

Gleason scores of prostate biopsy and radical prostatectomy specimens over the past 10 years: is there evidence for systematic upgrading?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900538-8

7 January 2021

Conformal treatment of prostate cancer with improved targeting: superior prostate-specific antigen response compared to standard treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900538-8

7 January 2021

Defining the optimal radiation dose with three-dimensional conformal radiation therapy for patients with nonmetastatic prostate carcinoma by using recursive partitioning techniques.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900538-8

7 January 2021

An ICRU 50 radiotherapy treatment chart.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900538-8

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900538-8

7 January 2021

The importance of adequate follow-up in defining treatment success after external beam irradiation for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900538-8

7 January 2021

The Incidence and Significance of Detectable Levels of Serum Prostate Specific Antigen After Radical Prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900538-8

7 January 2021

Prostate specific antigen regression and progression after androgen deprivation for localized and metastatic prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900538-8

7 January 2021

Posttreatment prostate-specific antigen nadir highly predictive of distant failure and death from prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900538-8

7 January 2021

The correlation of serial prostate specific antigen measurements with clinical outcome after external beam radiation therapy of patients for prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900538-8

7 January 2021

Practical application of biochemical failure definitions: what to do and when to do it

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900538-8

7 January 2021

10.1016/S0360-3016(03)00538-8

Identifiers

DOI

1 reference

19 April 2018

PubMed ID

12909210

1 reference

19 April 2018